Last 0.95 INR
Change Today 0.00 / 0.00%
Volume 0.0
CCBT On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 04/4/14 All times are local (Market data is delayed by at least 15 minutes).

chemcel bio-tech ltd (CCBT) Snapshot

Open
0.95
Previous Close
0.95
Day High
0.95
Day Low
0.95
52 Week High
04/17/13 - 0.95
52 Week Low
04/17/13 - 0.95
Market Cap
26.5M
Average Volume 10 Days
0.0
EPS TTM
0.30
Shares Outstanding
27.9M
EX-Date
--
P/E TM
3.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for CHEMCEL BIO-TECH LTD (CCBT)

Related News

No related news articles were found.

chemcel bio-tech ltd (CCBT) Related Businessweek News

No Related Businessweek News Found

chemcel bio-tech ltd (CCBT) Details

Chemcel Biotech Limited manufactures and sells agro chemicals comprising insecticides, fungicides, and plant growth promoters in India. It also produces bio-fertilizers and bio-pesticides. The company offers its products in the liquids, granules, and dusts forms. Chemcel Biotech Limited offers its products under Hexa Plus, Edge, Bolt 5, Propicel, Choke, Chaser, and Copcel brand names. The company was formerly known as Chemcel Products Limited and changed its name to Chemcel Biotech Limited in January 2001. Chemcel Biotech Limited was incorporated in 1995 and is based in Vijayawada, India.

Founded in 1995

chemcel bio-tech ltd (CCBT) Top Compensated Officers

Managing Director, Director and Chairman of S...
Total Annual Compensation: --
Compliance Officer and Company Secretary
Total Annual Compensation: --
Production Officer
Total Annual Compensation: --
Managing Director of Jetro Petro Biotech Priv...
Total Annual Compensation: --
Senior Accountant
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

chemcel bio-tech ltd (CCBT) Key Developments

BSE To Suspend Trading Of Chemcel Biotech Limited’s Securities

BSE will suspend trading in Chemcel Biotech Limited’s securities for non-compliance of several clauses that are part of the listing agreement. Trading in the shares will be suspended with effect from March 21, 2013. In case the company complies with all the provisions of the listing agreement on or before March 13, 2013, then trading in the shares will be suspended for five days up to March 28, 2013.

Chemcel Biotech Limited Reports Unaudited Consolidated and Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2012

Chemcel Biotech Limited reported unaudited consolidated and standalone earnings results for the second quarter and six months ended September 30, 2012. For the quarter, on a consolidated basis, the company reported total income from operations of INR 121,559,000 against INR 144,086,000 for the same period last year. Profit from operations before other income, finance costs and exceptional items was INR 5,813,000 against INR 10,167,000 for the same period last year. Profit from ordinary activities before tax was INR 3,001,000 against INR 5,700,000 for the same period last year. Net profit for the period was INR 3,001,000 or INR 0.11 per basic and diluted share against INR 5,700,000 or INR 0.20 per basic ad diluted share for the same period last year. For the six months, on a consolidated basis, the company reported total income from operations of INR 123,222,000 against INR 145,558,000 for the same period last year. Profit from operations before other income, finance costs and exceptional items was INR 6,412,000 against INR 5,356,000 for the same period last year. Profit from ordinary activities before tax was INR 790,000 against INR 253,000 for the same period last year. Net profit for the period was INR 790,000 or INR 0.03 per basic and diluted share against INR 253,000 or INR 0.01 per basic ad diluted share for the same period last year. For the quarter, on a standalone basis, the company reported total income from operations of INR 121,559,000 against INR 144,086,000 for the same period last year. Profit from operations before other income, finance costs and exceptional items was INR 5,833,000 against INR 10,207,000 for the same period last year. Profit from ordinary activities before tax was INR 3,021,000 against INR 5,740,000 for the same period last year. Net profit for the period was INR 3,021,000 or INR 0.11 per basic and diluted share against INR 5,740,000 or INR 0.21 per basic ad diluted share for the same period last year. For the six months, on a standalone basis, the company reported total income from operations of INR 123,222,000 against INR 145,558,000 for the same period last year. Profit from operations before other income, finance costs and exceptional items was INR 6,452,000 against INR 5,396,000 for the same period last year. Profit from ordinary activities before tax was INR 830,000 against INR 272,000 for the same period last year. Net profit for the period was INR 830,000 or INR 0.03 per basic and diluted share against INR 272,000 or INR 0.01 per basic ad diluted share for the same period last year.

Chemcel Biotech Limited, Board Meeting, Nov 15, 2012

Chemcel Biotech Limited, Board Meeting, Nov 15, 2012. Agenda: To approve the unaudited consolidated and standalone earnings results for the second quarter and six months ended September 30, 2012.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CCBT:IN 0.95 INR 0.00

CCBT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CCBT.
View Industry Companies
 

Industry Analysis

CCBT

Industry Average

Valuation CCBT Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHEMCEL BIO-TECH LTD, please visit www.chemcelbiotechltd.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.